Answers are grounded in this paper and cite their sources.
Complete staging of the malignant mass is a prerequisite for tailored therapy and is an important determinant of prognosis in cancer patients. Today, there is no doubt that among patients with esophageal cancer there is a role for endoscopy and endoscopic ultrasonography in local staging.1–3 Furthermore, there is widespread agreement that metastases of the liver, the lung, and the distant lymph nodes may be detected with high accuracy using radiological modalities such as ultrasonography and computed tomography (CT).1,3,4 In addition, fluoroscopy and barium swallow are used to delineate the relationship of the mass to anatomical key structures,1,3 even if some authors have presented data showing that conventional fluoroscopy is superior to endoscopy.5 However, there is a lack of complete staging in patients with esophageal cancer originating from the upper half of the organ and with the potential to invade the tracheobronchial system. Such invasion, classified as T4 esophageal cancer, implies local irresectability, even if the patient’s general condition and clinical data would allow such an operation. Thus, one of the principal goals of pretherapeutic staging is to exclude patients with a local irresectable mass from a primary operation.
No takes yet. Share an insight, caveat, or question.
Hermann Helmberger (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: